feed,title,long_url,short_url
Benzinga,Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst,https://benzinga.com/analyst-ratings/analyst-color/23/11/35920298/antibody-player-dianthus-therapeutics-has-potential-amid-active-m-a-landscape-in-co,https://da.gd/FUqS
